{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "ZICCUM AB", "longName": "Ziccum AB (publ)", "messageBoardId": "finmb_559878346", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": -0.4524896, "regularMarketPrice": 0.44, "marketState": "REGULAR", "fiftyTwoWeekHighChangePercent": -0.25801012, "fiftyTwoWeekLow": 0.071, "fiftyTwoWeekHigh": 0.593, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.18, "sharesOutstanding": 13806100, "fiftyDayAverage": 0.38448, "fiftyDayAverageChange": 0.055519998, "fiftyDayAverageChangePercent": 0.14440283, "twoHundredDayAverage": 0.2770825, "twoHundredDayAverageChange": 0.1629175, "twoHundredDayAverageChangePercent": 0.58797467, "marketCap": 6666572, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "priceHint": 4, "regularMarketChange": -0.002000004, "regularMarketTime": 1683904549, "regularMarketDayHigh": 0.487, "regularMarketDayRange": "0.44 - 0.487", "regularMarketDayLow": 0.44, "regularMarketVolume": 800, "regularMarketPreviousClose": 0.442, "bid": 0.457, "ask": 0.475, "fullExchangeName": "Frankfurt", "financialCurrency": "SEK", "regularMarketOpen": 0.462, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.369, "fiftyTwoWeekLowChangePercent": 5.1971827, "fiftyTwoWeekRange": "0.071 - 0.593", "fiftyTwoWeekHighChange": -0.153, "firstTradeDateMilliseconds": 1607324400000, "symbol": "7IZ.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Scheelev\u00e4gen 22", "city": "Lund", "zip": "223 63", "country": "Sweden", "website": "https://ziccum.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Ziccum AB (publ) develops dry powder preparations of biological pharmaceuticals. It develops and commercializes LaminarPace, a spray drying technology that dries liquid biopharmaceuticals, such as vaccines or protein therapeutics into a particle engineered powder product. The company was incorporated in 2017 and is headquartered in Lund, Sweden.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Ms. Ann  Gidner", "age": 56, "title": "Chief Exec. Officer", "yearBorn": 1966, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Frida  Hjelmberg", "age": 38, "title": "Chief Financial Officer", "yearBorn": 1984, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Fabrice  Rose", "age": 47, "title": "Scientific Director", "yearBorn": 1975, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}